SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Horlings H. M.)
 

Sökning: WFRF:(Horlings H. M.) > (2009) > Recurrent fusion of...

Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck

Persson, Marta, 1979 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Institute of Biomedicine, Department of Pathology
Andrén, Ywonne, 1956 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Institute of Biomedicine, Department of Pathology
Mark, Joachim (författare)
visa fler...
Horlings, H. M. (författare)
Persson, Fredrik, 1973 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Institute of Biomedicine, Department of Pathology
Stenman, Göran, 1953 (författare)
Gothenburg University,Göteborgs universitet,Institutionen för biomedicin, avdelningen för patologi,Institute of Biomedicine, Department of Pathology
visa färre...
 (creator_code:org_t)
2009-11-03
2009
Engelska.
Ingår i: Proceedings of the National Academy of Sciences. - : Proceedings of the National Academy of Sciences. - 1091-6490 .- 0027-8424. ; 106:44, s. 18740-4
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • The transcription factor gene MYB was identified recently as an oncogene that is rearranged/duplicated in some human leukemias. Here we describe a new mechanism of activation of MYB in human cancer involving gene fusion. We show that the t(6;9)(q22-23;p23-24) translocation in adenoid cystic carcinomas (ACC) of the breast and head and neck consistently results in fusions encoding chimeric transcripts predominantly consisting of MYB exon 14 linked to the last coding exon(s) of NFIB. The minimal common part of MYB deleted as the result of fusion was exon 15 including the 3'-UTR, which contains several highly conserved target sites for miR-15a/16 and miR-150 microRNAs. These microRNAs recently were shown to regulate MYB expression negatively. We suggest that deletion of these target sites may disrupt repression of MYB leading to overexpression of MYB-NFIB transcripts and protein and to activation of critical MYB targets, including genes associated with apoptosis, cell cycle control, cell growth/angiogenesis, and cell adhesion. Forced overexpression of miR-15a/16 and miR-150 in primary fusion-positive ACC cells did not significantly alter the expression of MYB as compared with leukemic cells with MYB activation/duplication. Our data indicate that the MYB-NFIB fusion is a hallmark of ACC and that deregulation of the expression of MYB and its target genes is a key oncogenic event in the pathogenesis of ACC. Our findings also suggest that the gain-of-function activity resulting from the MYB-NFIB fusion is a candidate therapeutic target.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Medicinska och farmaceutiska grundvetenskaper -- Cell- och molekylärbiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Basic Medicine -- Cell and Molecular Biology (hsv//eng)

Nyckelord

Adult
Aged
Base Sequence
Breast Neoplasms/*genetics/*pathology
Carcinoma
Adenoid Cystic/*genetics/*pathology
Chromosomes
Human
Pair 6/genetics
Chromosomes
Human
Pair 8/genetics
Female
Gene Expression Regulation
Neoplastic
Head and Neck Neoplasms/*genetics/*pathology
Humans
Leukemia-Lymphoma
Adult T-Cell/genetics
Male
MicroRNAs/genetics
Middle Aged
Molecular Sequence Data
Oncogene Proteins
Fusion/genetics/*metabolism
RNA
Messenger/genetics/metabolism
Translocation
Genetic

Publikations- och innehållstyp

ref (ämneskategori)
art (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Sök utanför SwePub

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy